Project Details
| Status | Active |
|---|---|
| Effective start/end date | 05/16/25 → 08/19/26 |
Funding
- Nkarta Incorporated: $115,920.32
Ntrust-1: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with Autoimmune Disease
- Yao, Qing Ping (PI)
- Gabig, Theodore (CoPI)
- Jandl, Thomas (CoPI)
- Lan, Fengshuo (CoPI)
- Lee, Christina (CoPI)
- Liu, Suhu (CoPI)
- Schuster, Michael (CoPI)
Project: Research